Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Details Narrative)

Stockholders' Deficit (Details Narrative) - USD ($)					1 Months Ended	3 Months Ended				9 Months Ended
Stockholders' Deficit (Details Narrative) - USD ($)	Feb. 03, 2020	Sep. 10, 2019	Jul. 19, 2019	Jun. 24, 2019	May 31, 2019	Mar. 31, 2020	Sep. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Mar. 31, 2020	Mar. 31, 2019	Feb. 06, 2020	Feb. 04, 2020	Aug. 31, 2019	Jun. 30, 2019	Dec. 09, 2014
Reverse stock split				one-for-five hundred (1:500)
Common stock, par value				$ 0.001		$ 0.001				$ 0.001					$ 0.001
Common stock, shares authorized	100,000,000			100,000,000		1,000,000,000				1,000,000,000		1,000,000,000	1,000,000,000		1,000,000,000
Preferred stock, shares authorized						1,500,005				1,500,005					1,500,005	500,000
Preferred stock, par value						$ 0.01				$ 0.01					$ 0.01
Common stock issued during period			20,000							17,343,368
Conversion price, decrease										$ 0.014
Conversion price, increase										$ 0.906
Conversion of principal and interest, aggregate amount										$ 922,754
Gain on extinguishment										(81,011)	$ (1,296,376)
Additional paid in capital						$ 48,879,086				$ 48,879,086					$ 45,713,322
Common stock reserved for future issuances						49,501,507				49,501,507
Share issued price per share			$ 1.99
Proceeds from issuance of common stock			$ 39,800								1,031,979
Consulting expenses										39,800
Number of shares issued for services, value						$ 21,000	$ 39,800	$ 100,000	$ 69,000
Number of restricted shares issued					78,000
Share Based Compensation										$ 225,312
Warrants to purchase common stock		1,000,000
Warrant exercise price		$ 2.00
Warrant expiration date		Sep. 10, 2022
Fair value of warrants		$ 984,810
Share-based Payment Arrangement, Option [Member]
Granted exercise price										$ 76.37
Share Based Compensation					$ 62,155
Grant options to purchase										59,644
Exercise price					$ 4.65
Risk free rate					2.42%
Dividend yield					0.00%
Fair value term					10 years
Expected volatility					268.00%
Option granted value					$ 248,620
Restricted Stock Units (RSUs) [Member]
Number of restricted shares issued					117,000
Granted exercise price					$ 4.25
Share based compensation arrangement by share based payment award options grant date fair value					$ 497,240
Share Based Compensation										$ 163,157
Unrecognized restricted stock units expense										303,006
Restricted Stock [Member]
Unvested stock option recognized						176,106				176,106
Consultant [Member] \| Engagement Agreement [Member]
Common stock, par value	$ 0.14
Consulting expenses	$ 21,000
Number of shares issued for services	150,000
Number of shares issued for services, value	$ 21,000
Chief Executive Officer [Member]
Common stock issued during period					58,500
Number of restricted shares issued					39,000
Option Description					The total 58,500 options have a term of 10 years from the date of grant and exercise price ranging from $4.25 to $4.675 per share. 1/3rd of these options shall vest every successive one-year anniversary, provided, that on each such vesting date, the Chief Executive Officer and Chief Scientific Officer are employed by the Company and subject to the other provisions of the employment agreement. The 58,500 stock options were valued using a Black-Scholes model with the following assumptions: stock price at valuation date of $4.25 based on quoted trading price on date of grant, exercise price of $4.65, dividend yield of zero, years to maturity of 10.00, a risk free rate of 2.42%, and expected volatility 268% for a total value of $248,620.
Chief Executive Officer [Member] \| Share-based Payment Arrangement, Option [Member]
Grant options to purchase					39,000
Chief Scientific Officer [Member] \| Share-based Payment Arrangement, Option [Member]
Grant options to purchase					19,500
Common Stock [Member]
Amount recorded to equity						1,153,264				1,153,264
Embedded conversion option derivatives										211,000
Fair market value of shares issued value										446,950
Loss on extinguishment										227,510
Gain on extinguishment										308,522
Additional paid in capital						$ 383,186				$ 383,186
Common stock reserved for future issuances						449,501,507				449,501,507
Number of shares issued for services						150,000	20,000	10,000	6,000
Number of shares issued for services, value						$ 150	$ 20	$ 10	$ 6
First Warrant [Member]
Warrants to purchase common stock														450,000
Warrant exercise price														$ 2.25
Second Warrant [Member]
Warrants to purchase common stock														300,000
Warrant exercise price														$ 3.33
Third Warrant [Member]
Warrants to purchase common stock														225,000
Warrant exercise price														$ 4.50
Warrant [Member]
Share Based Compensation										$ 984,810
Warrants outstanding and exercisable										1,975,059
Warrants expiration term description										As of March 31, 2020, there were 1,975,059 warrants outstanding and exercisable with expiration dates commencing May 2020 and continuing through August 2024, with a weighted average exercise price per share of $2.69.
Convertible Debt [Member]
Conversion price						$ 0.0532				$ 0.0532
Series A Preferred Stock [Member]
Preferred stock, shares authorized						500,000				500,000					500,000
Preferred stock, par value						$ 0.01				$ 0.01					$ 0.01
Preferred stock, shares issued						500,000				500,000					500,000
Preferred stock, shares outstanding						500,000				500,000					500,000
Number of shares issued for services
Number of shares issued for services, value